Additional Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Phoenix AZ. 85006
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Stanford CA. 94305
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Birmingham AL. 35205
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Boise ID. 83712
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Champaign IL. 61820
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Lexington KY. 40536
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Saint-Charles-Borromée QC. J6E 2B4
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Baltimore MD. 21201
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Chicago IL. 60611
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Sacramento CA. 95817
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Loma Linda CA. 92350
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Phoenix AZ. 85032
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Philadelphia PA. 19140
    View Details

  • The ARGiNAUT study is testing AZD8965 in adults with idiopathic pulmonary fibrosis who may or may not be taking treatments to reduce the buildup of scar tissue in the lungs.

    Research Site
    Kansas City KS. 66160
    View Details

  • Nebulized Human Amniotic Fluid in Patients With Interstitial Lung Disease

    Maule Stem Cell Research Institute
    Venice FL. 34292
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    Pulmonary Medicine Consultants
    McKinney TX. 75071
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    Innova Pharma Research
    Doral FL. 33172
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    New Life Medical Research
    Hialeah FL. 33012
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    New Access Research and Medical Services
    Miami FL. 33186
    View Details

  • A Study to Evaluate Safety, Tolerability and Pharmacokinetics of MNKD-201 in Patients With Idiopathic Pulmonary Fibrosis

    VALDI
    Fresno CA. 93720
    View Details